Antituberculosis Agents On The Horizon | OMICS International | Mycobacterial Diseases

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Webinars & Conferences

Nursing and Health Care

London, UK

Fungal Infections and Treatments

New York, USA

Antituberculosis Agents On The Horizon

Tuberculosis (TB) remains a global health problem despite the availability of efficacious drug therapies and efforts being made to decrease its incidence. TB is the second leading cause of death globally due to an infectious disease behind the human immunodeficiency virus (HIV). TB is caused by the infective bacillus organism Mycobacterium tuberculosis which primarily affects the lungs. There are two forms of TB: latent TB infection (LTBI) and active TB disease. In LTBI the organisms are non-replicating and the infected individual does not display symptoms of the infection. Active TB disease is seen when the organism slowly replicates inside the host cells. Patients exhibit signs and symptoms of the infection during active TB. M. tuberculosis is able to grow intracellularly in the host cell and prompt macrophage-induced drug tolerance to agents with antituberculosis activity.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on August, 2021